XBIO
XBIO
NASDAQ · Biotechnology

Xenetic Biosciences Inc

$3.29
-0.01 (-0.30%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target +1,010.3% upside
Low Target $23.38
Average Target $36.53
High Target $47.42
Current Price $3.29
Current
$3.29
Target
$36.53
$23.38 $36.53 avg $47.42
Scenario Analysis
Bear Case
$23.38
610.6%
Low target
Base Case
$36.53
+1,010.3%
Avg target
Bull Case
$47.42
+1,341.3%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$13.93
-76.4% from high
52-Week Low
$1.90
+73.2% from low
Target vs 52W High
$36.53
+162.2% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +2.7%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.3%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -15.1%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -54.0%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -43.5%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.6%